Latest Research

Editorial - Volume 17, Issue 5 - September 2015

Francois Bethoux, MD

September 1st 2015

The Role of Vitamin D in Multiple Sclerosis Pathology and Treatment: Answers and Opportunities

September 1st 2015

Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans

Richard E. Nelson, PhD;Yan Xie, PhD;Scott L. DuVall, PhD;Jorie Butler, PhD;Aaron W. C. Kamauu, MD, MPH, MS;Kristin Knippenberg, MFA;Markus Schuerch, PhD, MSc;Nadia Foskett, PhD;Joanne LaFleur, PharmD, MSPH

September 1st 2015

Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis

Cecilie Fjeldstad, PhD;Anette S. Fjeldstad, PhD;Gabriel Pardo, MD

September 1st 2015

Understanding Drivers of Employment Changes in a Multiple Sclerosis Population

Karin S. Coyne, PhD, MPH;Audra N. Boscoe, PhD;Brooke M. Currie, MPH;Amanda S. Landrian, BS;Todd L. Wandstrat, RPh, PharmD

September 1st 2015

Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate

J. Theodore Phillips, MD, PhD;Robert J. Fox, MD;Mark Novas, MD;Vissia Viglietta, MD, PhD;Krzysztof Selmaj, MD, PhD;Ralf Gold, MD;Eva Havrdova, MD;Gavin Giovannoni, MBBCh, PhD;Heather Abourjaily, PharmD;Amy Pace, ScD;Christophe Hotermans, MD, PhD;Leslie Meltzer, PhD

September 1st 2015

Medications Are Associated with Falls in People with Multiple Sclerosis

Dennis Bourdette, MD;Michelle H. Cameron, MD, PT;Lisa Karstens, PhD;Phu Hoang, PT, PhD;Stephen Lord, PhD, DSc

September 1st 2015

Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis

Sarah A. Morrow, MD, MS, FRCPC;Kristin M. Ikeda, MD, FRCPC;Donald H. Lee, MD, FRCPC;J. Alexander Fraser, MD, FRCPC;Seyed Mirsattari, MD, PhD, FRCPC

September 1st 2015

Editorial - Volume 17, Issue 4 - July 2015

Francois Bethoux, MD

Access to Preventive Health Care in Severely Disabled Women with Multiple Sclerosis

Brian Healy, PhD;Katharine Dobos, AB;Maria Houtchens, MD

Impact of Proactive Case Management by Multiple Sclerosis Specialist Nurses on Use of Unscheduled Care and Emergency Presentation in Multiple Sclerosis

Alison Leary, PhD, RN;Debbie Quinn, BSc (Hons), PGDip, RGN;Amy Bowen, MA

Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis (CARE-MS) Program

Cathy Meyer, RN, MSCN;Christina Caon, BSN, MSN, NP-C;Marie Namey, APN, MSCN;Lori Mayer, DNP, MSN, RN;Pedro Oyuela, MD, MPH;David H. Margolin, MD, PhD;Marco Rizzo, MD, PhD

Do Physical Therapy Interventions Affect Urinary Incontinence and Quality of Life in People with Multiple Sclerosis?

Valerie Block, PT;Monica Rivera, DPTSc;Marsha Melnick, PhD;Diane D. Allen, PhD

Fear of Falling Is Associated with Recurrent Falls in People with Multiple Sclerosis

Dennis N. Bourdette, MD;Rajarshi Mazumder, MD, MPH;William E. Lambert, PhD;Thuan Nguyen, MD, PhD;Michelle H. Cameron, MD, PT, MCR

Intolerance of Uncertainty

Kevin N. Alschuler, PhD;Meghan L. Beier, PhD

Selecting Rehabilitation Outcome Measures for People with Multiple Sclerosis

Susan E. Bennett, EdD;Evan T. Cohen, PhD, PT;Kirsten Potter, DPT;Diane D. Allen, PhD;Kathi G. Brandfass, MS;Gail L. Widener, PhD;Amy M. Yorke, PhD

Editorial - Volume 17, Issue 3 - May 2015

Francois Bethoux, MD

Abstracts from the 29th Annual Meeting of the Consortium of Multiple Sclerosis Centers

Association of Postural Sway with Disability Status and Cerebellar Dysfunction in People with Multiple Sclerosis

James McLoughlin, MSc;Christopher Barr, PhD;Maria Crotty, PhD;Stephen R. Lord, DSc;Daina L. Sturnieks, PhD

The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study

Alison M. Mackay, BSocSci (Psych)(Hons);Robert Buckingham, PhD;Raymond S. Schwartz, PhD;Suzanne Hodgkinson, PhD;Roy G. Beran, MD;Dennis J. Cordato, PhD

Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis

Caroline Bruun Helland, MD;Trygve Holmøy, MD, PhD;Pål Gulbrandsen, MD, PhD

Managing Neuropsychological Impairment in Multiple Sclerosis

Jana Pöttgen, Dipl-Psych;Stephanie Lau, Dipl-Päd;Iris Penner, PhD;Christoph Heesen, MD;Steffen Moritz, PhD

Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users

Yvonne C. Learmonth, PhD;Ian M. Rice, PhD;Teresa Ostler, PhD;Laura A. Rice, PhD;Robert W. Motl, PhD

Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis

Robert Yapundich, MD;Angela Applebee, MD;Francois Bethoux, MD;Myla D. Goldman, MD, MSc;George J. Hutton, MD;Michele Mass, MD;Gabriel Pardo, MD;Michael Klingler, MPH;Herbert R. Henney, PharmD;Andrew R. Blight, PhD;Enrique J. Carrazana, MD

Editorial - Volume 17, Issue 2 - March 2015

Francois Bethoux, MD

Evaluating the Theoretical Content of Online Physical Activity Information for People with Multiple Sclerosis

Celina H. Shirazipour, MHK;Colin P.T. Baillie, MSc;Karla Galaviz, PhD;Jocelyn W. Jarvis, MSc;Amy E. Latimer-Cheung, PhD

Walgreens Connected Care

Janeen DuChane, PhD;Bobby Clark, PhD;Francis Staskon, PhD;Rick Miller, RPh, MBA;Kathleen Love, RN;Ian Duncan, FSA, FIA, FCIA, MAAA

Patient Preferences for Attributes of Multiple Sclerosis Disease-Modifying Therapies

Leslie S. Wilson, PhD;Aimee Loucks, PharmD;Gregory Gipson, PharmD;Lixian Zhong, PhD;Christine Bui, BS;Elizabeth Miller, MA;Mary Owen, RN;Daniel Pelletier, MD, FRCPC;Douglas Goodin, MD;Emmanuelle Waubant, MD, PhD;Charles E. McCulloch, PhD

A Randomized Placebo-Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis

Theodore R. Brown, MD, MPH;April Slee, MS

The 7-Item Generalized Anxiety Disorder Scale as a Tool for Measuring Generalized Anxiety in Multiple Sclerosis

Alexandra L. Terrill, PhD;Narineh Hartoonian, PhD;Meghan Beier, PhD;Rana Salem, MA;Kevin Alschuler, PhD

...

15 16 17 18 19 20 21 22 23

...